Plus, the biotech that's more than tripled in 2017
U.S. stocks are trading lower this morning, due to a round of lackluster earnings reports. Among the stocks making moves this morning are global semiconductor company Advanced Micro Devices, Inc. (NASDAQ:AMD), online hotel platform Trivago (NASDAQ:TRVG), and medical research concern Cellect Biotechnology Ltd. (NASDAQ:APOP). Here's a closer look at what's moving shares of AMD, TRVG, and APOP.
AMD Drops After Disappointing Fourth-Quarter Forecast
Advanced Micro Devices reported third-quarter earnings that topped estimates, but expects sales to drop in the fourth quarter. The disappointing forecast pushed AMD shares 10% lower to $12.92, to test support atop their 200-day moving average. AMD's high short interest of 160.54 million shares accounts for 19.2% of the stock's available float. While the stock is short-sale restricted due to today's sell-off, the bears could remain in control of AMD, at least for now.
Trivago Touches a Fresh Low After Earnings
Trivago reported disappointing earnings, and the shares were last seen trading more than 16% lower at $9.00. The stock earlier touched a record low of $8.90. Near-term options traders have been scooping up puts over calls for Trivago, with the stock's Schaeffer's put/call open interest ratio (SOIR) of 2.26 showing more than twice as many puts than calls open among options with less than three months to expiration. However, the stock is now trading below peak front-month put open interest at the November 10 strike.
APOP Soars On Upbeat Stem Cell Data
Shares of Cellect Biotechnology are soaring after the company reported that its ApoGraft stem cell therapy technology is showing new promise, and could result in licensing deals. At last glance, the stock was up 19.5% at $9.51, and has now more than tripled year-to-date. APOP's big rally could attract bullish analysts to the shares, as only one brokerage firm is currently following the stock, offering up a "buy" rating.